DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Kandzari DE, Leon MB, Meredith I et al.
Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial
Program: Comparison of Safety and Efficacy With First-Generation Drug-Eluting
and Bare-Metal Stents.
JACC Cardiovasc Interv 2013;
DOI: 10.1016/j.jcin.2012.12.125.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.